Galapagos Enters Strategic Alliance in Diabetes and Obesity with Merck ... - Phramalive.com

MECHELEN, Belgium, January 9, 2009--Galapagos NV (Euronext: GLPG) announced today that it has entered into a multi-year global strategic alliance with Merck & Co., Inc. to develop potential new therapies in obesity and diabetes. Galapagos will be ...

Read more...

---

Kids and Health: Understanding diabetes is important - Seattle Post Intelligencer

Diabetes IS the name of a disorder in which the body has trouble regulating its carbohydrate and lipid metabolism. Untreated, it leads to elevated sugar levels. Diabetes is a disease that can strike children of all ages and across all backgrounds. It ...

Read more...

---

Key Challenges and Issues facing the World Hemoglobin A1c Monitoring ... - Businesswire.com

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ Million. The specific Test Types analyzed are HbA1c Laboratory Testing, and HbA1c Point of Care Testing & Self-Monitoring. The report provides separate comprehensive ...

Read more...

---

Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico - PR Newswire

PARSIPPANY, N.J. , Jan. 7 /PRNewswire/ -- Daiichi Sankyo, Inc., announced today that it has established a subsidiary -- Daiichi Sankyo de Puerto Rico, Inc. Daiichi Sankyo de Puerto Rico, Inc. is based in San Juan, and led by Jose Vazquez, Regional ...

Read more...

---

Glucose Control and Vascular Complications in Veterans with Type 2 ... - New England Journal of Medicine

Background The effects of intensive glucose control on cardiovascular events in patients with long-standing type 2 diabetes mellitus remain uncertain. Methods We randomly assigned 1791 military veterans (mean age, 60.4 years) who had a suboptimal ...

Read more...

---

Girl highlights diabetes fight - Evening Star

A TEN-year-old girl who lives with diabetes raised awareness of the plight of sufferers with a special event at her school. Ashleigh Connell held a Denims for Diabetes Day at Kingsfleet Primary in Old Felixstowe - with youngsters raising cash for ...

Read more...

---

Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary ... - PR Newswire

DEERFIELD, Ill. and SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Baxter International Inc. and Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the start of a Phase III clinical trial of Baxter's GAMMAGARD LIQUID [Immune Globulin Intravenous ...

Read more...

---